Rare Disease Clinical Research Training Program
Rare Disease Clinical Research Training Program
批准号:
10489961
负责人:
MARK L. BATSHAW
金额:
$16.15万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2027-08-31
关键词:
AddressAdultClinicalClinical ResearchCollaborationsCommunitiesCreativenessDisciplineEducation ProjectsEducational CurriculumEducational process of instructingEnvironmentFamilyFutureGeneticGoalsIndividualInstitutional RacismMedicineMentorsMentorshipMinority GroupsModelingParticipantPatientsPersonal SatisfactionPersonsPopulationRare DiseasesResearchResearch PersonnelScienceTherapeuticTrainingTraining ProgramsTranslational ResearchUnderrepresented Populationsbasecare deliverycareereducation researchexperienceflexibilityhealth equityhealth equity promotionimprovedlecturesmultidisciplinarynext generationnon-geneticprogramsrecruitskillstheoriesvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
The goal of the R25 Rare Disease Research (RDR) curriculum is to prepare a multidisciplinary and diverse group
of 50 Scholars per year to perform clinical and translational research in both genetic and non-genetic rare
disorders. This will be accomplished using a one-year 80 hr. blended teaching model. An objective of this
program is to create online modules, pod cast-style lectures, recorded didactic-style lectures and in person
experiences that enable learners from different disciplines and diverse backgrounds to actively participate in this
RDR curriculum. The field of RDR and care delivery recognizes that collaborative research and team science are
critical to improving therapeutic opportunities and wellbeing of the rare disease community. This concept serves
as the unifying theme of the curriculum. Furthermore, in addressing the issue of health equity and systemic
racism there is the need for training RDR leaders and practitioners from populations underrepresented in
medicine (UIM). As part of this objective, we will also prioritize the recruitment of Scholars from these
populations with the goal of having at least 20% of Scholars coming from populations UIM. Recruitment will
include the launching of a more expansive list of disciplines from which we will recruit scholars and creation of
an alumni participation program. We also will highlight how researchers and Scholars will “bring the table to the
participants” in RDR. By changing how the next generation of clinical researchers view recruitment and
engagement in the diverse family and patient rare disease communities, we expect to advance health equity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Career Development
-
批准号:8858730
-
项目类别:
-
资助金额:$8.6万
-
财政年份:2014
-
负责人:MARK L. BATSHAW
-
依托单位:
Longitudinal Study of Urea Cycle Disorders
-
批准号:8858722
-
项目类别:
-
资助金额:$74.17万
-
财政年份:2014
-
负责人:MARK L. BATSHAW
-
依托单位:
Biomarkers of Neurological Injury and Recovery in Urea Cycle Disorders
-
批准号:8858723
-
项目类别:
-
资助金额:$10.01万
-
财政年份:2014
-
负责人:MARK L. BATSHAW
-
依托单位:
Overall Adminstration of Rare Diseases Clinical Research Consortia (RDCRC)
-
批准号:8858731
-
项目类别:
-
资助金额:$17.22万
-
财政年份:2014
-
负责人:MARK L. BATSHAW
-
依托单位:
Pilot/Demonstration Clinical Research Projects Program
-
批准号:8858726
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2014
-
负责人:MARK L. BATSHAW
-
依托单位:
Nitric Oxide Supplementation as a Therapeutic Intervention in Argininosuccinate Lyase Deficiency
-
批准号:8858725
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2014
-
负责人:MARK L. BATSHAW
-
依托单位:
Rare Diseases Clinical Research Consorita (RDCRC) for the RDCR Network
-
批准号:8536435
-
项目类别:
-
资助金额:$19.9万
-
财政年份:2012
-
负责人:MARK L. BATSHAW
-
依托单位:
Investigation of Brain Nitrogen Metabolism in Partial Ornithine Trascarbamylase
-
批准号:8325108
-
项目类别:
-
资助金额:$8.29万
-
财政年份:2011
-
负责人:MARK L. BATSHAW
-
依托单位:
General Clinical Research Center
-
批准号:7919756
-
项目类别:
-
资助金额:$19.67万
-
财政年份:2009
-
负责人:MARK L. BATSHAW
-
依托单位:
Rare Diseases Clinical Research Consortia (RDCRC) for the RDCR Network
-
批准号:7932561
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2009
-
负责人:MARK L. BATSHAW
-
依托单位:
Gene Therapy for Urea Cycle Disorders
-
批准号:8474803
-
项目类别:
-
资助金额:$106.81万
-
财政年份:2008
-
负责人:MARK L. BATSHAW
-
依托单位:
Gene Therapy for Urea Cycle Disorders
-
批准号:8271464
-
项目类别:
-
资助金额:$119.6万
-
财政年份:2008
-
负责人:MARK L. BATSHAW
-
依托单位:
Gene Therapy for Urea Cycle Disorders
-
批准号:8846625
-
项目类别:
-
资助金额:$105.81万
-
财政年份:2008
-
负责人:MARK L. BATSHAW
-
依托单位:
Gene Therapy for Urea Cycle Disorders
-
批准号:8652988
-
项目类别:
-
资助金额:$107.09万
-
财政年份:2008
-
负责人:MARK L. BATSHAW
-
依托单位:
RARE DISEASES CRC: UREA CYCLE DISORDERS
-
批准号:7724756
-
项目类别:
-
资助金额:$91.5万
-
财政年份:2007
-
负责人:MARK L. BATSHAW
-
依托单位:
RARE DISEASES CRC: UREA CYCLE DISORDERS
-
批准号:7622818
-
项目类别:
-
资助金额:$117.21万
-
财政年份:2007
-
负责人:MARK L. BATSHAW
-
依托单位:
RARE DISEASES CRC: UREA CYCLE DISORDERS
-
批准号:7380788
-
项目类别:
-
资助金额:$120.21万
-
财政年份:2006
-
负责人:MARK L. BATSHAW
-
依托单位:
RARE DISEASES CRC: UREA CYCLE DISORDERS
-
批准号:7167049
-
项目类别:
-
资助金额:$125.0万
-
财政年份:2005
-
负责人:MARK L. BATSHAW
-
依托单位:
General Clinical Research Center
-
批准号:7195079
-
项目类别:
-
资助金额:$216.83万
-
财政年份:2005
-
负责人:MARK L. BATSHAW
-
依托单位:
General Clinical Research Center
-
批准号:7343263
-
项目类别:
-
资助金额:$218.84万
-
财政年份:2005
-
负责人:MARK L. BATSHAW
-
依托单位:
海外基金